Gara Jalqabaatti › Darmaatomiyoosiitisiis › Ohio
Qorannoo klinikaalii Darmaatomiyoosiitisiis Ohio keessatti
Qorannoo 5 Darmaatomiyoosiitisiis f Ohio keessatti hirmaatuu jiru.
Magaalota Ohio keessatti
Takkalaa qorannoo (Ingiliffa)
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- Ohio State University Comprehensive Cancer Center, Columbus
Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT03816345A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Cleveland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06455449A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- Cleveland Clinic, Cleveland
Namoota walitti qabaa jiraSadarkaa 3
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ful-2026 · NCT05895786Descartes-08 for Children, Adolescents, and Young Adults With Autoimmune Disorders
- Cincinnati Children's Hospital Medical Center, Cincinnati
Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 27-Ado-2026 · NCT07089121Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis
- Cleveland Clinic, Cleveland
Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 hanga 89 · Saalaa hunda · Haaromfame 08-Onk-2025 · NCT06857240Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.